Skip to main content
. 2020 Jul 7;36(2):392–400. doi: 10.3904/kjim.2019.446

Figure 1.

Figure 1.

Comparison of median serum (A) neutrophil gelatinase-associated lipocalin (NGAL) level, (B) Acute Physiology and Chronic Health Evaluation-II (APACHE-II) score, and (C) Sequential Organ Failure Assessment (SOFA) score between survivor and non-survivor group. Median serum NGAL level was 504.0 ng/mL in the survivor group and 743.0 ng/mL in the non-survivor group (p = 0.003). Median APACHE-II score was 24.0 in the survivor group and 31.0 in the non-survivor group (p < 0.001). Median SOFA score was 11.0 in the survivor group and 14.0 in the non-survivor group (p < 0.001). ap = 0.003, bp < 0.001.